8 A prospective cohort study involving seven psoriasis patients with type 2 diabetes treated with liraglutide for 12 weeks observed a mean PASI decrease from 15.7 to 2.2 and a DLQI improvement from 21.8 to 4.1.9 Additionally, reductions in HbA1c, BMI, and waist circumference were observed.9 One randomized, placebo-controlled trial involving 20 obese, glucose-tolerant patients with plaque psoriasis, however, found no significant improvement in PASI after 8 weeks of liraglutide
Matilainen O, Quirs PM, Auwerx J
Glendale patients choose us for: True medical supervision by a doctor Safe GLP-1 weight loss medications Customized dosing & monitoring Cardiovascular-informed care Transparent, affordable pricing Long-term weight loss success Your safety and long-term health are always the priority
This supplement is suitable for active people, athletes and those who care about their physical condition and metabolism